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We report on an extremely rare case of a giant solitary fibrous tumor (SFT) of the mesentery in a 65-year-old male
who was admitted to our hospital because of lower abdominal pain and abdominal fullness. Computed tomography
demonstrated a well-defined solid mass of 25 × 11 cm located in the lower abdomen, which was completely resected
during surgery. Histopathologically, this lesion had a heterogeneous cell population, mainly comprising spindle
cells with fibrous collagen proliferation, and various other cell populations exhibiting patternless growth.
Immunohistochemically, the tumor revealed strong and diffuse staining for CD34, bcl-2, and vimentin, and a
high mitotic index (seven mitoses per 10 high-power fields). We diagnosed this case as an SFT of the mesentery,
which is unusual according to a PubMed search that reported only nine such cases. Our case may be the largest
tumor reported to date, and only one retrieved case reported recurrence, although the lesion was exceptionally
large with deep invasion. Nonetheless, the lesion in our case was larger than that in the reported case of recurrence
and invasive to the ileum. Since surgery, there has been no evidence of recurrence. Hence, we propose that a large SFT
and high mitotic index may present risk factors for recurrence. Therefore, long-term careful follow-up is necessary in
such cases, although our case exhibited few risk factors for recurrence. A follow-up at 12 months after surgery found
no indications of recurrence.
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A solitary fibrous tumor (SFT) is a rare mesenchymal
neoplasm which often involves the thoracic cavity (pleura,
lung), and less frequently soft tissues and other visceral
and parenchymal organs, including the central nervous
system [1-3]. Although SFTs are well described in the
literature, those arising from the mesentery are very rare.
Here, we report on an extremely rare case of a giant soli-
tary fibrous tumor of the mesentery.Case presentation
A 65-year-old male with no significant personal or familial
medical history was admitted to our hospital 12 months
after a previous visit for symptoms of abdominal fullness
and lower abdominal pain. On clinical examination, rou-
tine blood results were normal, although the tumor marker* Correspondence: kiyo-n@tokyo-med.ac.jp
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unless otherwise stated.cancer antigen 19-9 levels (46.4 U/mL; normal level,
37.0 U/mL) were slightly elevated, whereas those of car-
cinoembryonic antigen were not (2.2 ng/mL; normal
level, <5.0 ng/mL). Contrast-enhanced computed tomog-
raphy demonstrated a 25 × 11 cm, well-circumscribed,
lobulated, heterogeneous mass in the abdominal cavity,
which contained several areas of necrosis and calcification
(Figure 1). Magnetic resonance imaging demonstrated a
well-circumscribed mass with heterogeneous high-signal
intensity on T2-weighted imaging (Figure 2). Computed
angiotomography demonstrated two feeding arteries infer-
ior to the mesentery and superior mesentery arteries
(Figure 3).
We decided to perform surgery and made a midline
incision of the abdomen; we resected a 25 × 13 cm firm,
encapsulated mass from the mesentery of the proximal
ileum. Because the tumor invaded part of the proximal
ileum, we performed combined local resection of the
ileum (about 30 cm) to ensure complete removal.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 (A) Abdominal computed tomography demonstrated a 25 × 11 cm, heterogeneous, lobulated mass in the abdominal cavity.
(B) Colonal view demonstrated lobulated mass.
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a 25.5 × 13 × 10 cm, well-defined, firm mass with necrotic
foci and a pale cut surface (Figure 4). Following histo-
logical examination, the tumor demonstrated necrosis,
hypercellularity, cellular atypia, heterogeneous cell popula-
tions (comprising mostly of spindle cells that exhibit
patternless growth), and fibrous collagen proliferation.
Immunohistochemically, the tumor showed strong and
diffuse staining for CD34, bcl-2, and vimentin; other
markers, such as pan-cytokeratins, EMA, desmin, alpha-
smooth muscle actin, and S-100 protein, were negative
and had a high mitotic index (seven mitoses per 10 high-
power fields (HPF)) (Figure 5). Based on morphological
and immunohistochemical findings (a large size, hypercel-
lular areas, cellular atypia, necrotic areas, and high mitoticFigure 2 Magnetic resonance imaging demonstrated a
well-circumscribed mass with a heterogeneous high signal
intensity on T2-weighted imaging.index (seven mitoses per 10 HPF)), a diagnosis of solitary
fibrous tumor of the mesentery with malignant potential
was determined.
Discussion
A SFT is a rare mesenchymal spindle cell neoplasm, first
described by Klemperer and Rabin in 1931 [1]. Although
the etiology of this lesion remains unclear, it has been
recently recognized that a SFT may occur in extrapleural
locations such as the lung, mediastinum, pericardium,
mesentery, peritoneum, extraperitoneal spaces, nose, and
paranasal sinuses [4]. However, a SFT arising from the
mesentery is unusual.
A search of the PubMed database (http://www.ncbi.nlm.
nih.gov/pubmed/) shows reports of only nine cases (Table 1)Figure 3 Computed angiotomography demonstrated two
feeding arteries, namely the inferior mesenteric artery (arrow)
and the superior mesenteric artery (dotted arrow). The green
area demonstrates a lobulated tumor.
Figure 4 Macroscopic examination of the tumor. (A) The tumor (25.5 × 13 × 10 cm) was a well-defined and firm mass. (B) The tumor demonstrated
several areas of necrotic, solid, and bleeding areas.
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from the literature (Table 1), there was a male preva-
lence, with a median age of 54 years (range, 33–73 years).
Although symptoms of SFTs may be unspecific, they may
be related to compression or dislocation of the organs
[14]. All cases were treated by surgery, as in our case. Our
literature review revealed that the mesenteric SFT
resected in our case may be the largest reported to date.
SFTs exhibit a wide spectrum of clinical findings;
therefore, surgical resection is necessary to arrive at a final
histopathological and immunohistochemical diagnosis
[15]. In general, SFTs comprise various cell types, with an




Figure 5 Pathological analysis of the resected specimen. (A) Typical areas
necrotic area. (D) An image demonstrating hypercellular areas with cellular atypon histopathological examination [6,15,16]. Immunohisto-
chemically, SFTs are commonly positive for CD34, bcl-2,
and vimentin, but rarely positive for S100 proteins,
desmin, actin, and cytokeratins [15]. In our case, the
tumor exhibited characteristics of an SFT by both
histopathological and immunohistochemical analyses.
Although the majority of SFTs are histopathologically
benign, up to 20% may be malignant [16]. As shown in
Table 1, recurrence was reported in only one case (No. 9).
In this case, the tumor was very large (21 cm) with deep in-
vasion to the inferior vena cava and abdominal aorta, and
all visible tissue was removed during surgery. In addition,
part of the inferior vena cava was resected to separate it(D)
(B) CD34
HE × 400
of a solitary fibrous tumor. (B) CD34 immunoreactivity. (C) A representative
ia and mitosis (7 mitoses/10 HPF).
Table 1 Solitary fibrous tumor of mesentery in English literature
Case no Age Sex Complaint Location Tumor size (cm) Treatment Follow-up (months) Outcome Reference
1 33 M NP Mesentery NP Surgery NP NP [5]
2 68 M Abdominal pain S-colon mesentery 18 Surgery NP NP [6]
3 53 M Abdominal pain Distal ileum mesentery 22 Surgery 1 Alive [7]
4 73 M Abdominal pain Mesentery 25 Surgery NP NP [8]
5 71 M Painless mass Small bowel mesentery 15.5 Surgery 12 Alive [9]
6 41 M Abdominal Pain Mesentery 23 Surgery 7 Alive [10]
7 26 M Abdominal fullness Proximal ileum
mesentery
12 Surgery 18 Alive [11]
8 36 M Abdominal Pain Rectum mesentery 15.5 Preoperative
RT Surgery
NP NP [12]
9 59 F Abdominal Pain Mesentery 21 Surgery 9 Recurrence [13]
10 65 M Abdominal Pain Proximal ileum
mesentery
25.5 Surgery 12 Alive Our case
NP, Not provided; M, Male; F, Female.
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removal of the tumor may be achieved, recurrence remains
a concern. Based on our observations, we propose that the
size of a mass may be a risk factor for recurrence.
The malignant variant of a SFT generally comprises a
large mass (>50 mm in diameter) and the histologic
features of malignant behavior are marked by hypercel-
lularity, necrosis, cellular atypia, and a high mitotic
index (>4 mitoses per 10 HPF) [17-19]. All SFTs have
the potential to become malignant; thus, gross tumor
examination and counting of mitoses are recommended
to assess the prognosis of any SFT [20]. In our case,
histological analysis revealed characteristics of hypercel-
lularity and invasiveness with nuclear pleomorphism and
tissue necrosis. Moreover, this tumor had a high mitotic
index (seven mitoses per 10 HPF). Based on these find-
ings, we considered our case to have malignant potential.
Although the natural history of extrapleural SFTs remains
unknown, long-term and careful follow-up may be neces-
sary, especially in cases with a large tumor and a high
mitotic index [21]. We followed this case for 12 months
after surgery and found no indications of recurrence.
Conclusions
Here, we reported an extremely rare case of a mesenteric
SFT in which the tumor may be the largest reported to
date. The tumor was completely removed during sur-
gery; however, careful follow-up is necessary because
cases with a large tumor and a high mitotic index may
have malignant potential.
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